First Time Loading...

Surmodics Inc
NASDAQ:SRDX

Watchlist Manager
Surmodics Inc Logo
Surmodics Inc
NASDAQ:SRDX
Watchlist
Price: 26.07 USD -3.16% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. [ Read More ]

The intrinsic value of one SRDX stock under the Base Case scenario is 21.51 USD. Compared to the current market price of 26.07 USD, Surmodics Inc is Overvalued by 17%.

Key Points:
SRDX Intrinsic Value
Base Case
21.51 USD
Overvaluation 17%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Surmodics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SRDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Surmodics Inc

Provide an overview of the primary business activities
of Surmodics Inc.

What unique competitive advantages
does Surmodics Inc hold over its rivals?

What risks and challenges
does Surmodics Inc face in the near future?

Has there been any significant insider trading activity
in Surmodics Inc recently?

Summarize the latest earnings call
of Surmodics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Surmodics Inc.

Provide P/S
for Surmodics Inc.

Provide P/E
for Surmodics Inc.

Provide P/OCF
for Surmodics Inc.

Provide P/FCFE
for Surmodics Inc.

Provide P/B
for Surmodics Inc.

Provide EV/S
for Surmodics Inc.

Provide EV/GP
for Surmodics Inc.

Provide EV/EBITDA
for Surmodics Inc.

Provide EV/EBIT
for Surmodics Inc.

Provide EV/OCF
for Surmodics Inc.

Provide EV/FCFF
for Surmodics Inc.

Provide EV/IC
for Surmodics Inc.

Show me price targets
for Surmodics Inc made by professional analysts.

What are the Revenue projections
for Surmodics Inc?

How accurate were the past Revenue estimates
for Surmodics Inc?

What are the Net Income projections
for Surmodics Inc?

How accurate were the past Net Income estimates
for Surmodics Inc?

What are the EPS projections
for Surmodics Inc?

How accurate were the past EPS estimates
for Surmodics Inc?

What are the EBIT projections
for Surmodics Inc?

How accurate were the past EBIT estimates
for Surmodics Inc?

Compare the revenue forecasts
for Surmodics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Surmodics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Surmodics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Surmodics Inc compared to its peers.

Compare the P/E ratios
of Surmodics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Surmodics Inc with its peers.

Analyze the financial leverage
of Surmodics Inc compared to its main competitors.

Show all profitability ratios
for Surmodics Inc.

Provide ROE
for Surmodics Inc.

Provide ROA
for Surmodics Inc.

Provide ROIC
for Surmodics Inc.

Provide ROCE
for Surmodics Inc.

Provide Gross Margin
for Surmodics Inc.

Provide Operating Margin
for Surmodics Inc.

Provide Net Margin
for Surmodics Inc.

Provide FCF Margin
for Surmodics Inc.

Show all solvency ratios
for Surmodics Inc.

Provide D/E Ratio
for Surmodics Inc.

Provide D/A Ratio
for Surmodics Inc.

Provide Interest Coverage Ratio
for Surmodics Inc.

Provide Altman Z-Score Ratio
for Surmodics Inc.

Provide Quick Ratio
for Surmodics Inc.

Provide Current Ratio
for Surmodics Inc.

Provide Cash Ratio
for Surmodics Inc.

What is the historical Revenue growth
over the last 5 years for Surmodics Inc?

What is the historical Net Income growth
over the last 5 years for Surmodics Inc?

What is the current Free Cash Flow
of Surmodics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Surmodics Inc.

Financials

Balance Sheet Decomposition
Surmodics Inc

Current Assets 79.8m
Cash & Short-Term Investments 35.2m
Receivables 23.1m
Other Current Assets 21.5m
Non-Current Assets 100.4m
PP&E 29.2m
Intangibles 70.5m
Other Non-Current Assets 724k
Current Liabilities 16.5m
Accounts Payable 2.6m
Accrued Liabilities 9.9m
Other Current Liabilities 4m
Non-Current Liabilities 41.6m
Long-Term Debt 29.4m
Other Non-Current Liabilities 12.2m
Efficiency

Earnings Waterfall
Surmodics Inc

Revenue
138.2m USD
Cost of Revenue
-28.5m USD
Gross Profit
109.7m USD
Operating Expenses
-97.6m USD
Operating Income
12.1m USD
Other Expenses
-6.5m USD
Net Income
5.5m USD

Free Cash Flow Analysis
Surmodics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SRDX Profitability Score
Profitability Due Diligence

Surmodics Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Positive Revenue Growth Forecast
42/100
Profitability
Score

Surmodics Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

SRDX Solvency Score
Solvency Due Diligence

Surmodics Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
70/100
Solvency
Score

Surmodics Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SRDX Price Targets Summary
Surmodics Inc

Wall Street analysts forecast SRDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SRDX is 60.18 USD with a low forecast of 44.44 USD and a high forecast of 78.75 USD.

Lowest
Price Target
44.44 USD
70% Upside
Average
Price Target
60.18 USD
131% Upside
Highest
Price Target
78.75 USD
202% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SRDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SRDX Price
Surmodics Inc

1M 1M
-5%
6M 6M
-9%
1Y 1Y
+9%
3Y 3Y
-56%
5Y 5Y
-38%
10Y 10Y
+18%
Annual Price Range
26.07
52w Low
17.67
52w High
38.49
Price Metrics
Average Annual Return -3.63%
Standard Deviation of Annual Returns 20.17%
Max Drawdown -72%
Shares Statistics
Market Capitalization 371.1m USD
Shares Outstanding 14 240 000
Percentage of Shares Shorted 3.95%

SRDX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Surmodics Inc Logo
Surmodics Inc

Country

United States of America

Industry

Health Care

Market Cap

371.1m USD

Dividend Yield

0%

Description

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The firm operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

Contact

MINNESOTA
Eden Prairie
9924 W 74th St
+19525007000.0
http://www.surmodics.com/

IPO

1998-03-04

Employees

389

Officers

CEO, President & Director
Mr. Gary R. Maharaj
Senior VP of Finance & Information Technology and CFO
Mr. Timothy J. Arens
Senior VP of Legal, General Counsel & Secretary
Mr. Gordon S. Weber
Senior VP & President of Medical Device Coatings
Mr. Charles W. Olson
Senior VP & President of Vascular Interventions
Ms. Teryl L. W. Sides
Corporate Controller, VP of Finance & Principal Accounting Officer
Mr. John D. Manders
Show More
Senior VP of Human Resources & President of In Vitro Diagnostics
Mr. Joseph J. Stich
Show Less

See Also

Discover More
What is the Intrinsic Value of one SRDX stock?

The intrinsic value of one SRDX stock under the Base Case scenario is 21.51 USD.

Is SRDX stock undervalued or overvalued?

Compared to the current market price of 26.07 USD, Surmodics Inc is Overvalued by 17%.